BioXcel Therapeutics Inc

NASDAQ:BTAI   2:40:10 PM EDT
17.58
-0.39 (-2.17%)
Other Pre-Announcement

Bioxcel Therapeutics Reports Q3 2022 Financial Results

Published: 11/10/2022 12:47 GMT
BioXcel Therapeutics Inc (BTAI) - Bioxcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational Highlights.
Top-line Pivotal Data for Tranquility Ii Trial Investigating Bxcl501 for Alzheimer's-related Agitation Expected in 1h 2023.
Qtrly Loss per Share $1.49.
Q3 Earnings per Share View $-1.35 -- Refinitiv Ibes Data (analyst estimates).